InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RIS | Ann: OFFICE: RIS: RIS Announce change of address and appointment of officer | 04/03/16 | 0 | 415 | |||
|
|||||||
RIS | Ann: WAV/RULE: RIS: RIS Group Limited - Waiver from NZAX Listing Rule 7.11.2 | 01/03/16 | 0 | 323 | |||
|
|||||||
RIS | Ann: MEMO: RIS: RIS: Share Consolidation and Name Change | 01/03/16 | 0 | 377 | |||
|
|||||||
RIS | Ann: GENERAL: RIS: RIS Annouce Share Consolidation and Name Change | 01/03/16 | 0 | 385 | |||
|
|||||||
RIS | Ann: SSH: RIS: SSH Notice VIG Ltd | 29/02/16 | 0 | 410 | |||
|
|||||||
RIS | Ann: HALT: RIS: RIS: Trading Halt and Information Discrepancy | 29/02/16 | 0 | 376 | |||
|
|||||||
RIS | Ann: SSH: RIS: SSH Notice - John Chow | 26/02/16 | 0 | 397 | |||
|
|||||||
RIS | Ann: SSH: RIS: SSH Notice - Michael Chow | 26/02/16 | 0 | 373 | |||
|
See All Discussions